Профиль Suven Life Sciences Ltd Dematerialsed
Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. It operates through the following business segments: Drug Discovery & Development Support Services and Drug Discovery & Clinical/research pipe Line. The Drug Discovery & Development Support Services segment offers research services specializing in Synthetic, Medicinal and Analytical Chemistry, In-vitro Assay development and Screening, Drug Metabolism & Pharmacokinetics, CNS Pharmacology (Behavioral Pharmacology, Microdialysis, Receptor Occupancy, Electrophysiology), Toxicology and Safety Pharmacology, Bioanalysis, and NCE Formulations.The Drug Discovery & Clinical/research Pipe Line segment includes serotonin 6 receptor, serotonin 4 receptor, histamine 3 receptor, Nicotinic acetylcholine (Alpha4beta2) receptor, muscarinic M1 receptor, muscarinic M4 receptor, multimodal (Dopaminergic and seretonergic receptor) and P2X purinoceptor 7 receptor. The company was founded on March 9, 1989 and is headquartered in Hyderabad, India.